摘要：2025年，国产工业CT领域出现密集的融资潮与多家上市公司业绩爆发，共同勾勒出这条高端制 造"生命线"的强势崛起轨迹。 在新能源汽车、半导体、精密电子、航空航天等高端制造领域，工业CT以其出色的无损透视与三维成 像能力，已成为把控产品质量、揭示内部缺陷的"火眼金睛"。过去，这一仪器市场长期被外资品牌主 导，国产设备往往面临技术与市场的双重围困。而今，政策扶持、技术突破与市场需求形成的合力，正 推动国产工业X射线检测设备加速"破局"——2025年集中爆发的融资潮与上市企业的亮眼业绩，共同勾 勒出其强势崛起的清晰轨迹。 一、融资潮涌：资本加码，国产力量加速集结 资本的嗅觉始终敏锐。近年来，国产工业CT领域的融资频率与规模显著攀升，至2025年已形成一波引 人注目的高峰。据不完全统计，今年已有至少5家产业链关键企业完成重要轮次融资，金额从数千万元 至数亿元不等，覆盖从核心部件、整机制造到智能成像解决方案的全链条。这股密集的资本暖流，不仅 体现了市场对国产替代逻辑与技术创新潜力的坚定信心，更为企业后续的研发攻坚、产能爬升与市场拓 展注入了决定性动能。 1、一目万相完成数千万元Pre-A轮融资 苏州一目万相科技有 ...

Core Insights - The article highlights the recent financing round completed by Yimu Wanxiang Technology Co., Ltd., amounting to several tens of millions of RMB, aimed at expanding market presence, production capacity, technology research and development, and working capital [1][7]. Company Overview - Yimu Wanxiang was established in July 2021 and is headquartered in Suzhou, Jiangsu. The company focuses on the integration of multi-modal imaging and artificial intelligence in both industrial and medical fields [3]. - The main business includes the research, production, and sales of industrial intelligent imaging detection equipment, medical surgical imaging devices, and intelligent surgical assistance platforms [3]. - The core team has nearly 20 years of experience in the X-ray industry, providing a strong technical foundation and rich industry experience [3]. Technology and Applications - The company's core technology integrates the latest X-ray imaging technology with artificial intelligence, enabling efficient acquisition of high-quality images and high detection quality [5]. - Yimu Wanxiang's X-ray detection systems are widely applied in various fields, including electronics, automotive, aerospace, new energy, oil and gas, materials, archaeology, and scientific research, demonstrating strong market performance [6]. - In the industrial sector, the company has developed the "Micro Imaging" professional analysis system by deeply integrating DR, CT, and other imaging technologies with AI algorithms, offering differentiated high-precision detection solutions [7]. - In the medical sector, the self-developed WIL Meta® series products provide advanced, efficient, precise, and safe surgical equipment, featuring high integration, compact design, fast scanning, large imaging, and AI empowerment [7]. Financing History - The company completed its angel round financing on March 25, 2022, with investment from Aix Guanggu, although the specific amount was not disclosed [7]. - On May 20, 2025, Yimu Wanxiang completed a Pre-A round financing, with investments from Su Chuangtou and Guo Fa Wen Xin, reaching several tens of millions of RMB [7].